Mark H. Breedlove - Director at Cognition Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark H. Breedlove since 12/22/2023

Holdings reported by Mark H. Breedlove for Cognition Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 404K $425K $1.05 Oct 13, 2021 By Breedlove Family Limited Partnership.
Common Stock 7.61K $7.99K $1.05 Oct 13, 2021 Direct
Series A-1 Convertible Preferred Stock 0 Oct 13, 2021 By Breedlove Family Limited Partnership. Common Stock
Series A-2 Convertible Preferred Stock 0 Oct 13, 2021 By Breedlove Family Limited Partnership. Common Stock
Series B-1 Convertible Preferred Stock 0 Oct 13, 2021 By Breedlove Family Limited Partnership. Common Stock
Series B Convertible Preferred Stock 0 Oct 13, 2021 By Breedlove Family Limited Partnership. Common Stock
Warrant (Right to Buy) 0 Oct 13, 2021 By Breedlove Family Limited Partnership. Common Stock

Transactions reported by Mark H. Breedlove for Cognition Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.